FG-M108

FG-M108 · FutureGen Biopharmaceutical (Beijing) Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FG-M108, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer [Phase 3]